Hpv Warts

HPV warts are benign skin or mucosal growths caused by infection with human papillomavirus (HPV), a widespread virus transmitted primarily through direct contact. After entering small breaks in the epithelium, HPV infects basal keratinocytes and alters their growth as infected cells mature, producing the characteristic thickened lesion. Their occurrence and spread therefore connect virology with behavior: skin-to-skin contact, sexual contact for anogenital warts, and sharing contaminated personal items can influence transmission, while hand hygiene, avoiding picked lesions, barrier protection, and appropriate vaccination can reduce risk for some HPV types. Understanding these links supports prevention, diagnosis, and treatment decisions.

Hpv Warts - Related Videos

Research

JoVE Journal - Behavior

Local Hyperthermia for Warts Treatment

0 Views •

2024

Here, we present a protocol for local hyperthermia, a new and effective therapeutic for treating warts. We also showcase its safety and efficacy as an independent treatment.

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

0 Views •

Cited by 4 •

2019

Human papillomavirus (HPV) RNA chromogenic in situ hybridization is considered to be one of the gold standards for active human papillomavirus infection detection within tumors. It allows the visualization of HPV E6-E7 mRNA expression with localization and semiquantitative evaluation of its signal.

Research

JoVE Journal - Medicine
Free Sample

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

0 Views •

Cited by 41 •

2014

The presence of high-risk HPV in head and neck tumor tissue is associated with favorable outcomes. The recently developed RNA in situ hybridization technique called RNAscope allows direct visualization of HPV E6/E7 mRNA in FFPE tissue sections.

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

0 Views •

Cited by 9 •

2012

Characterizing T-cell epitopes of pathogens that cause localized infections such as human papillomavirus is a challenge because of limited number of T cells in circulation. A method is described in which rare T cells were isolated and were characterized starting with a very small number of cells.

Suppressing Hepatitis B Virus Replication Using Viral Antigen-Specific T Cells

0 Views •

2025

The video demonstrates an assay using human induced pluripotent stem cell (iPSC)-derived CD8+ T cells to inhibit hepatitis B virus (HBV) replication in mice. These T cells, engineered with HBV-specific receptors, are transferred into transgenic mice. Replication-competent HBV genome plasmids are then injected directly into the liver, enabling viral DNA uptake. Once viral antigens are expressed and presented by hybrid MHC-I molecules, the engineered T cells recognize and bind to these complexes.

View All Results

FAQs

Related Topics